DATAMEDRIX GMBH
Desconocido
diaRNAgnosis: A novel platform for the direct profiling of circulating cell free ribonucleic acids in biofluids
DATAMEDRIX GMBH
participó en un
H2020:
H2020-MSCA-RISE-2020
Circulating cell-free ribonucleic acids (ccfRNAs) represent an emerging and important class of molecules, able to provide significant clinic...
2020-10-02 - 2025-05-31 | Financiado
2020-10-02 - 2025-05-31 | Financiado
InterTAU: Integrative structural biology of pathological tau protein an appealing therapeutic target for Alzh...
DATAMEDRIX GMBH
participó en un
H2020:
H2020-MSCA-RISE-2019
There is an enormous and unmet medical need to find efficient methods of prevention, diagnosis and disease- modifying therapies for neurodeg...
2019-11-27 - 2025-06-30 | Financiado
2019-11-27 - 2025-06-30 | Financiado
* No se disponen de datos de la empresa actual.